Washington, DC 20006-5349
HELPLINE
Today, the Meso Foundation wrote a letter to the acting administrator of the EPA urging the agency to account for legacy asbestos when evaluating asbestos risk and the magnitude of the asbestos problem. This letter came as a response to the EPA’s decision to exclude legacy uses of asbestos in its problem formulation. This issue is separate from the recently publicized ‘significant new use rule.’ You can read more here.
EPA_Legacy_Comment_MesoFoundation
On this episode of MesoTV, our Patients Services Director, Julie White, RN, BSN, OCN, sits down with our new Executive Director, Brian Lepacek, MDiv, CAE,
The legal panel was moderated by Cheryl Bruner, Esq. The panel included:Joseph Belluck, Esq., Belluck & Fox, LLPDawn Besserman, Esq., MHRFMKathy Farinas, Esq., Dean Omar
Mesothelioma is a cancer that affects a small amount of people who are exposed to asbestos. Why do some people develop mesothelioma and others do
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
